Ophthalmology-service providers see significant PE interest
Cataract-focused groups are of high interest
Most assets are sub-$10 mln or $5 mln in EBITDA
Healthcare sponsors and dealmakers are calling the highly-fragmented ophthalmology universe the “next dental” or the “next derm,” and sources say there’s no shortage of buyers looking through the lens of opportunities. Indeed, the space that remained untouched for a long ...
This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period